Market
What will be the outcome of the Japanese tooth regrowth drug trials by mid-2025?
3
Resolution / Starting Odds
Significant tooth regrowth • 25%
Moderate tooth regrowth • 25%
Minimal tooth regrowth • 25%
No tooth regrowth • 25%
Clinical trial results published by Kyoto University Hospital
Story
Japanese Drug Aims to Regrow Teeth by Targeting USAG-1 Protein
Dec 14, 2024, 06:00 AM
Japanese researchers are testing a pioneering drug aimed at regrowing teeth by targeting the USAG-1 protein, potentially offering an alternative to dentures and implants. Clinical trials began in October at Kyoto University Hospital, with the drug being administered to adults who have lost at least one tooth. The treatment has shown promising results in animal testing, including mice and ferrets. The research, led by Katsu Takahashi from the Medical Research Institute Kitano Hospital in Osaka, aims to make the drug available for children by 2030, focusing initially on those with congenital conditions causing tooth loss.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Significant Improvement • 25%
No Improvement • 25%
Harmful Effects • 25%
Moderate Improvement • 25%
Other • 25%
Regulatory hurdles • 25%
Efficacy issues • 25%
Safety concerns • 25%
Cosmetic dentistry • 25%
Dental implants alternative • 25%
Other • 25%
Orthodontic applications • 25%
United States • 25%
European Union • 25%
Japan • 25%
Other • 25%
No significant effect on lifespan • 25%
Proven effective with significant lifespan extension • 25%
Proven effective with moderate lifespan extension • 25%
Negative effects or halted trials • 25%
China • 25%
Other • 25%
European Union • 25%
United States • 25%
Negative efficacy and safety concerns • 25%
Negative efficacy, but good safety • 25%
Positive efficacy and safety results • 25%
Positive efficacy, but safety concerns • 25%
